NEUROFIBROMATOSIS
Clinical trials for NEUROFIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Modified cold sore virus injected to fight disfiguring skin tumors
Disease control Recruiting nowThis early-stage study is testing whether a modified virus (IMLYGIC) can be safely injected into skin tumors caused by neurofibromatosis type 1 (NF1) to shrink them. The virus is designed to infect and destroy tumor cells. Researchers will enroll 10 adults with NF1 who have at le…
Matched conditions: NEUROFIBROMATOSIS
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
Decade-Long quest to map the progression of a rare genetic disorder
Knowledge-focused Recruiting nowThis study aims to observe and understand how neurofibromatosis type 2 (NF2) develops over time. Researchers will follow 269 participants, aged 8 to 75, for up to ten years, tracking tumor growth and its effects on hearing, speech, and swallowing. The goal is to gather detailed i…
Matched conditions: NEUROFIBROMATOSIS
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Apr 04, 2026 05:06 UTC
-
Mapping the Real-World impact of a complex genetic disorder
Knowledge-focused Recruiting nowThis study aims to gather detailed information about adults living with neurofibromatosis type 1 (NF1) in Russia. Researchers will observe 200 patients in their regular care settings to document their symptoms, tumor characteristics, overall health, and quality of life. The goal …
Matched conditions: NEUROFIBROMATOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC